Centurium Capital
Suite 1008, TWO Pacific Place
Hong Kong,
Website:
centurium.com
Firm Size
- Assets Under Management (AUM):$4.6 Billion
- Number of Funds:5
- Employees:
- Firm Type:Private Equity
- Focus Areas:
Software & Technology
Healthcare
Consumer
Description
Centurium Capital is a private equity firm based in Hong Kong. The company focuses on investing in high-potential companies in China. It was founded in 2017 by David Li and Fu Wei, both former senior partners at the global private equity firm, The Carlyle Group.
Centurium Capital primarily targets investments in sectors such as consumer, healthcare, technology, and media. The firm aims to support companies in achieving their long-term growth potential and to create value through long-term partnerships.
The company has a team of seasoned professionals with extensive expertise in private equity investments. They work closely with portfolio companies, providing strategic guidance and operational support to maximize their growth prospects.
Centurium Capital has gained recognition for its investment approach focused on the domestic Chinese market. As of now, the firm has successfully raised billions of dollars in capital commitments from institutional investors and family offices.
The firm has made notable investments in various companies, including Luckin Coffee, China's leading coffee chain, and China Biologic Products, a leading plasma-based biopharmaceutical company.
Overall, Centurium Capital is a prominent private equity firm in Hong Kong, with a strong focus on investing in promising Chinese companies and supporting their long-term growth.